Company / R&D Expense
CASTLE BIOSCIENCES INC R&D Expense History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$51.9M
FY2025
5-year range
$29.6M / $53.6M
FY2021-FY2025
Trend
-0.4%
vs FY2024
Sector context
#79 of 110
Health Care
What the data says
At $52M, CASTLE BIOSCIENCES INC's r&d expense ranks #79 of 110 in the Health Care sector. Declined from $54M to $52M over the past 2 years.
Based on SEC 10-K filings.
$52M in FY2025 with a 5-year CAGR of +31.4%.
Declined from $54M to $52M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +4.9%
- 5-Year CAGR
- +31.4%
- 10-Year CAGR
- -
Sector benchmark
#79 of 110 in Health CareTop 72% of 110This company $51.9M Sector average $298.2M
▼
-82.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +31.4%, indicating consistent growth.
- In FY2025, r&d expense decreased 0.4% year-over-year.
- Ranks #79 out of 110 companies in the Health Care sector.
- Peak r&d expense was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $51.9M | -0.4% |
| FY2024 | $52.0M | -2.9% |
| FY2023 | $53.6M | +19.4% |
| FY2022 | $44.9M | +51.5% |
| FY2021 | $29.6M | +123.6% |
| FY2020 | $13.3M | +79.5% |
| FY2019 | $7.4M | +52.1% |
| FY2018 | $4.9M | - |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026